Search research articles
Contact Us
Filters
Showing results (1401-1410 of 1,475) with videos related to
Page
of 148
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
NPJ Parkinson'S Disease
|
December 17, 2019
Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease
Gregory M Pontone, Nadeeka Dissanayka, Liana Apostolova, et al.
NPJ Parkinson'S Disease
|
June 19, 2020
Erratum: Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease
Gregory M Pontone, Nadeeka Dissanayaka, Liana Apostolova, et al.
The New England Journal of Medicine
|
June 27, 2018
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E Herndon, et al.
Plos One
|
March 3, 2012
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
John H Sampson, Robert J Schmittling, Gary E Archer, et al.
British Journal of Cancer
|
October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
D A Reardon, J E Herndon, K B Peters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 12, 2018
SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response
Ingrid Faber, Alberto Rolim Muro Martinez, Carlos Roberto Martins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
John H Sampson, Amy B Heimberger, Gary E Archer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2017
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A Batich, Elizabeth A Reap, Gary E Archer, et al.
Blood
|
July 20, 2011
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
Duane A Mitchell, Xiuyu Cui, Robert J Schmittling, et al.
Page
of 148
Search research articles
Search
Showing results (1401-1410 of 1,475) with videos related to
Sort By:
Page
of 148
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
NPJ Parkinson'S Disease
|
December 17, 2019
Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease
Gregory M Pontone, Nadeeka Dissanayka, Liana Apostolova, et al.
NPJ Parkinson'S Disease
|
June 19, 2020
Erratum: Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease
Gregory M Pontone, Nadeeka Dissanayaka, Liana Apostolova, et al.
The New England Journal of Medicine
|
June 27, 2018
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E Herndon, et al.
Plos One
|
March 3, 2012
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
John H Sampson, Robert J Schmittling, Gary E Archer, et al.
British Journal of Cancer
|
October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
D A Reardon, J E Herndon, K B Peters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 12, 2018
SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response
Ingrid Faber, Alberto Rolim Muro Martinez, Carlos Roberto Martins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
John H Sampson, Amy B Heimberger, Gary E Archer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2017
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A Batich, Elizabeth A Reap, Gary E Archer, et al.
Blood
|
July 20, 2011
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
Duane A Mitchell, Xiuyu Cui, Robert J Schmittling, et al.
Page
of 148